Inhibiting phosphoinositide 3-kinases

Cancer Biol Ther. 2005 May;4(5):546-7. doi: 10.4161/cbt.4.5.1669. Epub 2005 May 15.
No abstract available

Publication types

  • Comparative Study
  • Comment

MeSH terms

  • Androstadienes / pharmacology*
  • Animals
  • Antibiotics, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Drug Therapy, Combination
  • Glioma / drug therapy
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Phosphoinositide-3 Kinase Inhibitors*
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins c-akt / metabolism
  • Recombinant Proteins
  • Signal Transduction / drug effects*
  • Sirolimus / therapeutic use
  • Transplantation, Heterologous
  • Xenograft Model Antitumor Assays

Substances

  • Androstadienes
  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Phosphoinositide-3 Kinase Inhibitors
  • Recombinant Proteins
  • 17-hydroxywortmannin
  • Proto-Oncogene Proteins c-akt
  • Sirolimus